INVO   $0.86  -4.44% Market Closed After Close 0.85 -1.16%

INVO Bioscience Inc
Total Cash 942.93K
totalCashPerShare 0.241
EBITDA -4.62M
Total Debt 5.38M
quickRatio 0.15
currentRatio 0.3
Total Revenue 5.77M
debtToEquity 394.316
Revenue/Share 2.088
ROA -0.26569998
ROE
grossProfits
freeCashflow 1.44M
operatingCashflow -3.68M
earningsGrowth
revenueGrowth 4.814
grossMargins 0.44889998
ebitdaMargins -0.80156
operatingMargins -1.03611
profitMargins -1.22799
enterpriseValue 16.78M
forwardPE
floatShares 3.88M
sharesOutstanding 3.91M
sharesShort 1.95K
sharesShortPriorMonth 121.33K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.04%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -1.59
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -7.08M
trailingEps 0.69%
forwardEps -0.20%
enterpriseToEbitda -3.63
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2023
institutionsCount 12
lastUpdated Oct. 16, 2024, 9:59 p.m.